PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10970676-6	2000	Treatment of the mice with the selective COX1 inhibitor, piroxicam, attenuated the hypophagic responses to IL-1 and LPS.	Piroxicam	57-66	interleukin 1 complex	Mus musculus	107-111	
7858871-8	1994	The potentiation of LPS-stimulated release of IL-1-like activity produced by indomethacin, 100 microM, piroxicam, 100 microM, or sodium meclofenamate, 10 microM, was inhibited by prostaglandin E2, (PGE2) 10 ng ml-1.	Piroxicam	103-112	interleukin 1 complex	Mus musculus	46-50	
7858871-10	1994	Aspirin, 100 microM, indomethacin, 100 nM to 10 microM, piroxicam, 1 to 100 microM, and sodium meclofenamate, 10 nM, all potentiated cell-associated IL-1-like activity in LPS- stimulated macrophages.	Piroxicam	56-65	interleukin 1 complex	Mus musculus	149-153	
2968844-2	1988	IL-1 production was initially studied in the presence of piroxicam and indomethacin, both inhibitors of prostaglandin biosynthesis.	Piroxicam	57-66	interleukin 1 complex	Mus musculus	0-4	
3079606-5	1986	Inhibitors of the CO pathway (indomethacin, piroxicam, and ibuprofen) caused a dose-dependent augmentation in the LPS-induced IL 1 response.	Piroxicam	44-53	interleukin 1 complex	Mus musculus	126-130